The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo-Reference-Cited by-同舟云学术

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

Published:2009-07 Issue:7 Volume:60 Page:1895-1905
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Kremer Joel M.,Bloom Bradley J.,Breedveld Ferdinand C.,Coombs John H.,Fletcher Mark P.,Gruben David,Krishnaswami Sriram,Burgos-Vargas Rubén,Wilkinson Bethanie,Zerbini Cristiano A. F.,Zwillich Samuel H.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24567/fullpdf

Reference28 articles.

1. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials;Strand;Am J Manag Care,2007

2. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [published errata appear in N Engl J Med 2001;344:76 and N Engl J Med 2001;344:240];Bathon;N Engl J Med,2000

3. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment;Breedveld;Arthritis Rheum,2006

4. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial;Klareskog;Lancet,2004

5. Secondary loss of efficacy with TNFα-antagonists: data from the STURE registry;Van Vollenhoven;Arthritis Rheum,2005

Cited by 481 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib;Arthritis Research & Therapy;2024-08-27

2. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus;Digestive and Liver Disease;2024-08

3. Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis;PLOS ONE;2024-07-31

4. Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials;Rheumatology and Therapy;2024-07-03

5. The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis;PLOS ONE;2024-06-21